Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Mannatech, Incorporated stock logo
MTEX
Mannatech
$9.41
-1.6%
$10.06
$6.75
$16.49
$17.88M0.924,505 shs1,823 shs
Onconetix, Inc. stock logo
ONCO
Onconetix
$4.73
-24.9%
$6.11
$4.05
$1,190.00
$305.30M3.5103,041 shs302,077 shs
Sol-Gel Technologies Ltd. stock logo
SLGL
Sol-Gel Technologies
$7.52
+9.0%
$6.83
$3.34
$16.50
$20.95M1.132,773 shs102,998 shs
Synergy CHC Corp. (Uplisting) stock logo
SNYR
Synergy CHC Corp. (Uplisting)
$2.08
-9.2%
$2.01
$0.12
$10.00
$19.12MN/A625,604 shs52,493 shs
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Mannatech, Incorporated stock logo
MTEX
Mannatech
0.00%-6.78%-10.84%-5.17%+17.87%
Onconetix, Inc. stock logo
ONCO
Onconetix
0.00%-24.90%-34.30%-55.84%-99.02%
Sol-Gel Technologies Ltd. stock logo
SLGL
Sol-Gel Technologies
0.00%+3.87%+0.67%+31.98%-14.56%
Synergy CHC Corp. (Uplisting) stock logo
SNYR
Synergy CHC Corp. (Uplisting)
0.00%-0.95%-12.61%-41.90%+207,999,900.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Mannatech, Incorporated stock logo
MTEX
Mannatech
1.4608 of 5 stars
0.05.00.00.03.61.70.0
Onconetix, Inc. stock logo
ONCO
Onconetix
0.3469 of 5 stars
0.04.00.00.02.00.00.0
Sol-Gel Technologies Ltd. stock logo
SLGL
Sol-Gel Technologies
3.016 of 5 stars
3.55.00.00.03.01.70.0
Synergy CHC Corp. (Uplisting) stock logo
SNYR
Synergy CHC Corp. (Uplisting)
3.8928 of 5 stars
3.80.00.00.03.33.31.9
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Mannatech, Incorporated stock logo
MTEX
Mannatech
0.00
N/AN/AN/A
Onconetix, Inc. stock logo
ONCO
Onconetix
0.00
N/AN/AN/A
Sol-Gel Technologies Ltd. stock logo
SLGL
Sol-Gel Technologies
3.00
Buy$40.00431.91% Upside
Synergy CHC Corp. (Uplisting) stock logo
SNYR
Synergy CHC Corp. (Uplisting)
3.50
Strong Buy$10.00380.77% Upside

Current Analyst Ratings Breakdown

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Mannatech, Incorporated stock logo
MTEX
Mannatech
$115.04M0.16N/AN/A$5.64 per share1.67
Onconetix, Inc. stock logo
ONCO
Onconetix
$2.52M120.95N/AN/A$3.01 per share1.57
Sol-Gel Technologies Ltd. stock logo
SLGL
Sol-Gel Technologies
$12.10M1.73N/AN/A$1.67 per share4.50
Synergy CHC Corp. (Uplisting) stock logo
SNYR
Synergy CHC Corp. (Uplisting)
$33.59M0.57N/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Mannatech, Incorporated stock logo
MTEX
Mannatech
-$2.24M-$0.10N/AN/A-1.26%-15.62%-3.76%8/11/2025 (Estimated)
Onconetix, Inc. stock logo
ONCO
Onconetix
-$37.41MN/A0.00N/A-2,758.89%N/A-48.09%8/27/2025 (Estimated)
Sol-Gel Technologies Ltd. stock logo
SLGL
Sol-Gel Technologies
-$27.24M-$4.70N/AN/AN/A-81.75%-27.17%-22.49%8/14/2025 (Estimated)
Synergy CHC Corp. (Uplisting) stock logo
SNYR
Synergy CHC Corp. (Uplisting)
N/AN/A0.003.53N/AN/AN/AN/AN/A

Latest ONCO, SNYR, MTEX, and SLGL Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
6/12/2025Q1 2025
Onconetix, Inc. stock logo
ONCO
Onconetix
N/A$21.25N/A-$0.53N/A$0.10 million
5/23/2025Q1 2025
Sol-Gel Technologies Ltd. stock logo
SLGL
Sol-Gel Technologies
N/A-$3.20N/A-$3.20N/A$1.03 million
5/15/2025Q1 2025
Synergy CHC Corp. (Uplisting) stock logo
SNYR
Synergy CHC Corp. (Uplisting)
$0.07$0.10+$0.03$0.10$9.03 million$8.17 million
5/13/2025Q1 2025
Mannatech, Incorporated stock logo
MTEX
Mannatech
N/A-$0.80N/A-$0.80N/A$26.56 million
3/31/2025Q4 2024
Synergy CHC Corp. (Uplisting) stock logo
SNYR
Synergy CHC Corp. (Uplisting)
$0.10$0.01-$0.09$0.01$10.55 million$10.30 million
3/26/2025Q4 2024
Mannatech, Incorporated stock logo
MTEX
Mannatech
N/A$1.20N/A$1.20N/A$29.01 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Mannatech, Incorporated stock logo
MTEX
Mannatech
$0.202.13%N/AN/A N/A
Onconetix, Inc. stock logo
ONCO
Onconetix
N/AN/AN/AN/AN/A
Sol-Gel Technologies Ltd. stock logo
SLGL
Sol-Gel Technologies
N/AN/AN/AN/AN/A
Synergy CHC Corp. (Uplisting) stock logo
SNYR
Synergy CHC Corp. (Uplisting)
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Mannatech, Incorporated stock logo
MTEX
Mannatech
0.44
1.25
0.74
Onconetix, Inc. stock logo
ONCO
Onconetix
N/A
0.06
0.05
Sol-Gel Technologies Ltd. stock logo
SLGL
Sol-Gel Technologies
N/A
5.81
5.81
Synergy CHC Corp. (Uplisting) stock logo
SNYR
Synergy CHC Corp. (Uplisting)
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
Mannatech, Incorporated stock logo
MTEX
Mannatech
12.98%
Onconetix, Inc. stock logo
ONCO
Onconetix
23.89%
Sol-Gel Technologies Ltd. stock logo
SLGL
Sol-Gel Technologies
26.18%
Synergy CHC Corp. (Uplisting) stock logo
SNYR
Synergy CHC Corp. (Uplisting)
N/A

Insider Ownership

CompanyInsider Ownership
Mannatech, Incorporated stock logo
MTEX
Mannatech
41.50%
Onconetix, Inc. stock logo
ONCO
Onconetix
3.10%
Sol-Gel Technologies Ltd. stock logo
SLGL
Sol-Gel Technologies
66.51%
Synergy CHC Corp. (Uplisting) stock logo
SNYR
Synergy CHC Corp. (Uplisting)
56.60%
CompanyEmployeesShares OutstandingFree FloatOptionable
Mannatech, Incorporated stock logo
MTEX
Mannatech
2501.90 million1.10 millionNot Optionable
Onconetix, Inc. stock logo
ONCO
Onconetix
1264.55 million57.17 millionN/A
Sol-Gel Technologies Ltd. stock logo
SLGL
Sol-Gel Technologies
502.79 million9.33 millionOptionable
Synergy CHC Corp. (Uplisting) stock logo
SNYR
Synergy CHC Corp. (Uplisting)
409.19 millionN/AN/A

Recent News About These Companies

Synergy CHC Announces 7th Quarter of Profitability

New MarketBeat Followers Over Time

Media Sentiment Over Time

Mannatech stock logo

Mannatech NASDAQ:MTEX

$9.41 -0.15 (-1.61%)
Closing price 06/13/2025 03:50 PM Eastern
Extended Trading
$9.30 -0.10 (-1.07%)
As of 06/13/2025 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels. Mannatech, Incorporated was incorporated in 1993 and is headquartered in Flower Mound, Texas.

Onconetix stock logo

Onconetix NASDAQ:ONCO

$4.73 -1.57 (-24.90%)
Closing price 06/13/2025 04:00 PM Eastern
Extended Trading
$4.46 -0.27 (-5.60%)
As of 06:59 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Onconetix, Inc., a biotechnology company, focuses on the research, development, and commercialization of solutions for men's health and oncology. It offers Entadfi, an FDA-approved, once daily pill that combines finasteride and tadalafil for the treatment of benign prostatic hyperplasia; and Proclarix, an in vitro protein-based blood diagnostic test for prostate cancer. The company was formerly known as Blue Water Biotech, Inc. and changed its name to Onconetix, Inc. in December 2023. Onconetix, Inc. was incorporated in 2018 and is headquartered in Cincinnati, Ohio.

Sol-Gel Technologies stock logo

Sol-Gel Technologies NASDAQ:SLGL

$7.52 +0.62 (+8.99%)
Closing price 06/13/2025 04:00 PM Eastern
Extended Trading
$7.37 -0.15 (-1.99%)
As of 05:11 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Sol-Gel Technologies Ltd., together with its subsidiary Sol-Gel Technologies Inc., develops topical dermatological drugs for patients with severe skin conditions in Israel. The company offers Twyneo, a once-daily, non-antibiotic topical cream for the treatment of acne vulgaris; and Epsolay, a once-daily topical cream for the treatment of papulopustular (subtype II) rosacea. It also develops SGT-610 that is in Phase 3 clinical trials for the treatment of Gorlin Syndrome; and SGT-210, which has completed Phase I clinical trial, to treat rare hyperkeratinization disorders, such as Darier, PC, PPK, Olmsted, etc. In addition, the company is also involved in the development of generic topical dermatological drug products. It has collaboration with Padagis Israel Pharmaceuticals Ltd; and license agreements with Galderma Holding SA and Searchlight Pharma Inc. Sol-Gel Technologies Ltd. was incorporated in 1997 and is headquartered in Ness Ziona, Israel.

Synergy CHC Corp. (Uplisting) stock logo

Synergy CHC Corp. (Uplisting) NASDAQ:SNYR

$2.08 -0.21 (-9.17%)
As of 06/13/2025 04:00 PM Eastern

Synergy CHC Corp. engages in the marketing and distribution of branded health and wellness products. The company was founded on December 29, 2010 and is headquartered in Westbrook, ME.